This biotech company uses AI to enable doctors to share research to cure diseases

On this week’s episode of the ‘Leaders in Innovation’ podcast, Owkin cofounder and CEO Thomas Clozel breaks down his data-driven research approach. At AI biotech company Owkin, cofounder and CEO Thomas Clozel is rethinking cancer and disease research through an entirely new lens—and aiming to break down barriers in healthcare along the way. Read Full Story